
The Global Emerging Markets Group
Description
The Global Emerging Markets Group (GEM) is a prominent alternative investment firm headquartered in New York, established in 1993. With a strategic focus on global emerging markets, GEM provides flexible capital solutions to small and mid-cap companies across a diverse range of sectors. The firm is recognized for its long-term investment horizon and its ability to deploy capital through various structured finance instruments, distinguishing itself from traditional venture capital or private equity firms.
GEM's core investment strategy revolves around providing growth capital through mechanisms such as Private Investments in Public Equity (PIPEs), share subscription facilities, and other bespoke financing arrangements. This approach primarily targets companies that are either publicly traded or are in the process of listing on public exchanges, offering them access to capital for expansion, acquisitions, or general corporate purposes. The firm's flexibility allows it to tailor financing solutions to meet the specific needs of its portfolio companies, often acting as a strategic partner beyond just a capital provider.
The firm manages over $3.4 billion in assets, reflecting its significant presence in the alternative investment landscape. GEM's typical investment facilities range from $5 million to $200 million, demonstrating its capacity to support a wide spectrum of capital requirements. Their global reach extends across Asia, Latin America, Africa, and Eastern Europe, covering sectors including technology, healthcare, natural resources, and consumer goods. This broad mandate underscores GEM's commitment to identifying and fostering growth opportunities in dynamic emerging economies worldwide.
Investor Profile
The Global Emerging Markets Group has backed more than 67 startups, with 14 new investments in the last 12 months alone. The firm has led 63 rounds, about 94% of its total and boasts 15 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Private Equity, Series Unknown, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, Canada.
- Strong thematic focus on Biotechnology, Blockchain, Software.
- Led 14 rounds in the past year.
- Typical check size: $5M – $200M.
Stage Focus
- Private Equity (40%)
- Series Unknown (27%)
- Post Ipo Equity (16%)
- Debt Financing (7%)
- Initial Coin Offering (3%)
- Post Ipo Debt (1%)
- Series A (1%)
- Series B (1%)
- Convertible Note (1%)
Country Focus
- United States (39%)
- Switzerland (7%)
- Canada (7%)
- India (6%)
- Singapore (6%)
- France (6%)
- Qatar (3%)
- Ireland (3%)
- Hong Kong (1%)
- South Africa (1%)
Industry Focus
- Biotechnology
- Blockchain
- Software
- Financial Services
- Renewable Energy
- Pharmaceutical
- Information Technology
- Transportation
- Biopharma
- Cryptocurrency
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.